Delivery Order SPE2DB22D3016-SPE2DB25FAWC5

Award Date 5/12/25
Potential Completion Date 5/13/25
Potential Value $63K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RABAVERT rabies vaccine with diluents. The contract has a total ceiling value of $17,123.97 and a performance period through May 2, 2025. It is a firm fixed-price, non-set-aside contract. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of RABAVERT rabies vaccine with diluents. The contract has a ceiling value of $34,244.25 and a period of performance through April 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RABAVERT rabies vaccine with diluents. The contract has a ceiling value of $20,034.00 and a period of performance through January 29, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a $31,868.64 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RABAVERT Rabies Vaccine with diluents, with a period of performance ending on January 14, 2025. The contract was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RABAVERT rabies vaccine with diluents, with a ceiling value of $1,105.74 and a completion date of June 14, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of RABAVERT rabies vaccine with diluents, with a ceiling value of $4,191.60 and a period of performance through January 16, 2025. The contract is not designated as a set-aside and was awarded on a full and open competition basis. Amerisourcebergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,158.18 and provides for the delivery of RABAVERT rabies vaccine with diluents. The contract has a firm-fixed price pricing type and runs through August 2, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of RABAVERT rabies vaccine with diluents. The contract has a ceiling value of $4,191.60 and a period of performance through May 13, 2025. It is a firm-fixed-price contract type. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RABAVERT rabies vaccine with diluents, with a ceiling value of $2,095.80 and a period of performance through March 11, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RABAVERT rabies vaccine with diluents, with a ceiling value of $38,902.50 and a period of performance through April 2, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAWC5
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RABAVERT rabies vaccine with diluents. The contract has a ceiling value of $62,874.00 and a completion date of May 13, 2025. It is not set aside for any particular business type.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is likely part of that larger contract, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military and government healthcare programs.

Generated 8/17/25, 1:00 AM